Cellis is developing Macrophage Drug Conjugates (MDCs) which is a breakthrough, new class of therapy for solid tumors. Cellis uses allogeneic macrophages conjugated with therapeutic medications for treatment of several solid tumors. Our focus is on glioblastoma, ovarian and pancreatic cancer.
Cellis AG
Verified listing
-
Founded2018
-
Employees in Switzerland1-9
- Website
- Get directions
- Bookmark
- Share
- Report
- prev
- next